Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Doximity, Inc. Class A Common Stock (NY:DOCS)

53.21 +0.43 (+0.81%)
Official Closing Price Updated: 7:00 PM EDT, Apr 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Doximity, Inc. Class A Common Stock

< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
20 21 Next >
This Is the Biggest Problem With Doximity's Stock
The stock is near its 52-week low but it definitely isn't cheap. 
Via The Motley Fool
NYSE: DOCS Shareholder Notice: Investigation over Potential Securities Laws Violations by Doximity, Inc.
San Diego, CA -- (SBWIRE) -- 08/21/2023 -- Doximity, Inc. is under investigation over potential securities laws violations in connection with certain financial statements. 
Via SBWire
1 Growth Stock Down Nearly 40% to Buy and Hold For 10 Years
The company's shares recently dropped following its latest quarterly update. 
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Down 39.9%, Is Doximity a Buy on the Dip?
Find out if everyday investors should be as upset about the company's outlook revision as Wall Street was. 
Via The Motley Fool
Time to Cut and Run on This 1 Formerly Promising Digital Health Stock?
It's time to shorten the leash on Doximity after a surprise about-face on financial guidance. 
Via The Motley Fool
Why Doximity Stock Took A Nosedive Today
Doximity, Inc. (NYSE: DOCS) shares fell Wednesday after the company issued second-quarter and full-year 2023 revenue guidance below estimates. 
Via Benzinga
Why Shares of Doximity Are Falling Wednesday
Despite strong financials, the company downgraded yearly guidance. 
Via The Motley Fool
The Latest Analyst Ratings for Doximity
Via Benzinga
Why Doximity Stock Plunged 29% This Week
The healthcare-centric networking service announced layoffs and reduced its full-year guidance even after posting strong quarterly results. Here's what happened. 
Via The Motley Fool
Topics Workforce
Exposures Layoff
DOCS INVESTOR NEWS: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Doximity, Inc. Investors With Losses in Excess of $100K to Inquire About Securities Class Action Investigation – DOCS
From The Rosen Law Firm, P.A.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For August 9, 2023
Via Benzinga
Is Teladoc Health a Buy Now?
Second-quarter results pleased the market, but can the stock keep climbing? 
Via The Motley Fool
Why Cutera Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Wednesday's Session
Gainers Tango Therapeutics, Inc. (NASDAQ: TNGX) climbed 85.2% to $7.09 after gaining 11% on Tuesday. Tango Therapeutics recently posted a narrower quarterly loss. 
Via Benzinga
Why Is DraftKings (DKNG) Stock Down Today?
DraftKings (DKNG) stock is falling on Wednesday as investors in the gambling company react to a deal for rival Penn Entertainment (PENN). 
Via InvestorPlace
PENN Stock Alert: The $2 Billion Reason Penn Entertainment Is Up Today
Penn Entertainment (PENN) stock is rising higher on Wednesday after the company signed a massive deal with Disney's (DIS) ESPN. 
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Why Is Nxu (NXU) Stock Down 32% Today?
Nxu (NXU) stock is taking a beating on Wednesday after the power storage company announced pricing of a public share offering. 
Via InvestorPlace
Why Is Doximity (DOCS) Stock Down 23% Today?
Doximity (DOCS) stock is falling hard on Wednesday after the medical cloud services company released earnings for fiscal Q1 2024! 
Via InvestorPlace
Why EMCORE Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket
Gainers 180 Life Sciences Corp. (NASDAQ: ATNF) shares surged 109.2% to $1.58 in pre-market trading after falling over 6% on Tuesday. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
It's time to start Wednesday with an overview of all the biggest pre-market stock movers traders need to know about this morning! 
Via InvestorPlace
Upstart, Doximity, 2U And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
U.S. stock futures traded higher this morning on Wednesday. Here are some big stocks recording losses in today’s pre-market trading session. Doximity, Inc. (NYSE: DOCS) shares dipped 24.4% to $24.80 in... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Doximity Announces Fiscal 2024 First Quarter Financial Results
From Doximity
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For August 3, 2023
Via Benzinga
Better Buy: Teladoc Health vs. Doximity
Each company has lagged the market recently, but likely due to no fault of its own. 
Via The Motley Fool
Doximity to Release Fiscal 2024 First Quarter Results on August 8, 2023
From Doximity
Via Business Wire
4 Top Stocks to Buy in July and Hold Forever
The long-term growth stories of these businesses are still in their early chapters -- now may be the perfect time to buy. 
Via The Motley Fool
3 No-Brainer Growth Stocks to Buy in July and Hold for the Next Decade
These overlooked stocks have bright futures, but they're trading at knocked-down prices. 
Via The Motley Fool
Doximity Report Indicates Permanent Role for Telemedicine in Health Care
From Doximity
Via Business Wire
< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
20 21 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback